Coronary Artery Disease

Aims & Scope

Coronary Artery Disease welcomes reports of original research with a clinical emphasis, including observational studies, clinical trials, translational research, novel imaging, pharmacology and interventional approaches as well as advances in laboratory research that contribute to the understanding of coronary artery disease.

Each issue of Coronary Artery Disease is divided into four areas of focus: Original Research articles, Review in Depth articles by leading experts in the field, Editorials and Images in Coronary Artery Disease.

The Editorials will comment on selected original research published in each issue of Coronary Artery Disease, as well as highlight controversies in coronary artery disease understanding and management.

Submitted artcles undergo a preliminary review by the editor.

Some articles may be returned to authors without further consideration.

Those being considered for publication will undergo further assessment and​ peer-review by the editors and those invited to do so from a reviewer pool.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2
2024	1.50

Journal Rank

Year	Value
2024	12409

Journal Citation Indicator

Year	Value
2024	492

SJR (SCImago Journal Rank)

Year	Value
2024	0.460

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	70

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The right ventricle in pulmonary hypertension

  Citation: 354

  Authors: Kelly M., Nick H.S., Lewis J.

• Endothelial dysfunction and coronary artery disease

  Citation: 200

  Authors: Yasushi, Amir

• Drug-eluting stents: caution and concerns for long-term outcome

  Citation: 190

  Authors: Renu, Andrew, Giulio, Frank D.

• The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus

  Citation: 177

  Authors: Sidney, Barry, N. Bradly, Melvin J., Kenneth E.

• Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome

  Citation: 165

  Authors: Martina B., Andreas M., Volker

• Biomechanical interaction between cap thickness, lipid core composition and blood pressure in vulnerable coronary plaque: impact on stability or instability

  Citation: 157

  Authors: Gérard, Jacques, Gilles

• Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease

  Citation: 152

  Authors: Satwat, Qiu Tang

• Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease

  Citation: 151

  Authors: Yoshihiro, Akira, Toyokazu, Tetsuya, Takuya, Haruki, Akira, Kenji, Hiroaki

• Vascular endothelial function in patients with slow coronary flow

  Citation: 143

  Authors: Alpay Turan, Ahmet, Irfan, Ergün, Nurzen, Ramazan, Ertan, Izzet, Feridun, Necip, Saim, Emrah, Sengul

• Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms

  Citation: 142

  Authors: Robert W., Shixiong, John A.

---